1303588-27-3, name is 7-Chloro-1,2,3,4-tetrahydro-1,8-naphthyridine, belongs to chlorides-buliding-blocks compound, is considered to be a conventional heterocyclic compound, which is widely used in drug synthesis. The chemical synthesis route is as follows. Computed Properties of C8H9ClN2
Under a nitrogen atomosphere, 1 , 2, 3,4-tetrahydro- 1 ,8-naphthyridine (110; 1 .2g, 7. 12mmol) was dissolved in DME (40mL) along with , 3-(tri fluromethyl)-phenylboronic acid (2.03g, 1 0.68 mmol), Cs2C03 (4.64 g, 14.24 mmol) and Pd(dppf)Cl2 (297 mg, 0.356 mmol). The reaction mixture was stirred at 90 C overnight. The solid was filtrated. The filtration was then diluted with H2O and extracted with ethyl acetate. The combined organic layers were washed with brine, dried over Na2S04 and then concentrated in vacuo. The residue was purified by column chromatography to afford 7-(3-(trifluoromethyl)phenyl)- 1 ,2, 3 , 4-tetrahydro- 1 ,8-naphthyridine (111 ; 1.25g, 63%). MS (ESI) calcd for C sH nFs^ (m/z) 278.27.
The synthetic route of 1303588-27-3 has been constantly updated, and we look forward to future research findings.
Reference:
Patent; SIRTRIS PHARMACEUTICALS, INC.; NG, Pui, Yee; BLUM, Charles; MCPHERSON, Lauren; PERNI, Robert, B.; VU, Chi, B.; AHMED, Mohammed, Mahmood; DISCH, Jeremy, S.; WO2011/59839; (2011); A1;,
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics